KURA icon

Kura Oncology

152 hedge funds and large institutions have $1.24B invested in Kura Oncology in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 54 increasing their positions, 54 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

11% less capital invested

Capital invested by funds: $1.4B → $1.24B (-$156M)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

66% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 29

Holders
152
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.39M
Puts
$1.9M
Net Calls
Net Calls Change

Top Buyers

1 +$27.6M
2 +$15M
3 +$12.3M
4
DM
Deerfield Management
New York
+$9.77M
5
AG
Artal Group
Luxembourg
+$8.43M

Top Sellers

1 -$29.6M
2 -$26.4M
3 -$13.6M
4
VA
VR Adviser
New York
-$12M
5
GPP
Great Point Partners
Connecticut
-$10.4M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.12M
77
$1.09M
78
$1.08M
79
$1.06M
80
$1.06M
81
$1.04M
82
$949K
83
$937K
84
$861K
85
$856K
86
$852K
87
$835K
88
$814K
89
$795K
90
$737K
91
$722K
92
$720K
93
$677K
94
$653K
95
$651K
96
$629K
97
$542K
98
$473K
99
$454K
100
$444K